Agenus (AGEN) Return on Capital Employed Growth (1y) (2012 - 2026)
Agenus (AGEN) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 2,400.00 |
| 10 | Agenus | 233.53 Mn | 198.53 Mn | 33.74 Mn | 202,667.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202,667.00 |
| Dec 31, 2025 | 111,933.00 |
| Sep 30, 2025 | 870.00 |
| Jun 30, 2025 | 292,738.00 |
| Mar 31, 2025 | -157,354.00 |
| Dec 31, 2024 | -86,575.00 |
| Sep 30, 2024 | 9,458.00 |
| Jun 30, 2024 | -292,071.00 |
| Mar 31, 2024 | -38,316.00 |
| Dec 31, 2023 | -18,897.00 |
| Sep 30, 2023 | -6,703.00 |
| Jun 30, 2023 | -7,129.00 |
| Mar 31, 2023 | -10,010.00 |
| Dec 31, 2022 | -5,168.00 |
| Sep 30, 2022 | -10,041.00 |
| Jun 30, 2022 | 38,473.00 |
| Mar 31, 2022 | 16,278.00 |
| Dec 31, 2021 | 15,599.00 |
| Sep 30, 2021 | 27,322.00 |
| Jun 30, 2021 | -8,100.00 |